Inventor

Jeannie M. Arruda

Inventor
San Diego, CA, US

Overview

28→
Patents
2006–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 28 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes24%
C07CAcyclic or carbocyclic compounds8%
PatentTitleYear
10,000,456Polycyclic compounds as lysophosphatidic acid receptor antagonists20189,624,182'Compounds as lysophosphatidic acid receptor antagonists'20179,090,573'Compounds as lysophosphatidic acid receptor antagonists'20158,778,983'Polycyclic compounds as lysophosphatidic acid receptor antagonists'20148,664,220'Polycyclic compounds as lysophosphatidic acid receptor antagonists'20148,609,852'Thiazolyl mGluR5 antagonists and methods for their use'20138,546,431'5-lipoxygenase-activating protein (FLAP) inhibitors'20138,524,748'Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors'20138,497,381'Antagonists of prostaglandin D2 receptors'20138,455,499'Alkyne antagonists of lysophosphatidic acid receptors'20138,440,707'Antagonists of lysophosphatidic acid receptors'20138,399,666'5-lipoxygenase-activating protein (FLAP) inhibitors'20138,362,044'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20138,273,780'Polycyclic antagonists of lysophosphatidic acid receptors'20128,247,602'Antagonists of prostaglandin D2 receptors'20128,242,145'Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors'20128,242,143'Thiazolyl mGluR5 antagonists and methods for their use'20128,217,066'Compounds as lysophosphatidic acid receptor antagonists'20128,071,807'Antagonists of prostaglandin D2 receptors'20118,067,445'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20118,058,300'Polycyclic antagonists of lysophosphatidic acid receptors'20118,048,902'Antagonists of lysophosphatidic acid receptors'20117,977,359'5-lipdxygenase-activating protein (FLAP) inhibitors'20117,910,561'Inhibitors of Akt activity'20117,879,882'Thiazolyl mglur5 antagonists and methods for their use'20117,687,541'Prodrugs of diaryl-2-(5H)-furanone cyclooxygenase-2 inhibitors'20107,465,730'Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds'20087,087,601'Metabotropic glutamate receptor-5 modulators'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2018Based in San Diego, CA, US· patent location history
2011–2013Patents assigned to ARRUDA JEANNIE M (15)· patent assignee history
2011–2015Patents assigned to HUTCHINSON JOHN HOWARD (13)· patent assignee history
2011–2018Patents assigned to AMIRA PHARMACEUTICALS INC (12)· patent assignee history
2011–2014Patents assigned to SEIDERS THOMAS JON (11)· patent assignee history
2011–2015Patents assigned to WANG BOWEI (11)· patent assignee history
2011–2013Based in LaJolla, CA, US· patent location history
2011Based in La Jolla, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ARRUDA JEANNIE Mself152011–2013
HUTCHINSON JOHN HOWARD132011–2015
AMIRA PHARMACEUTICALS INC122011–2018
SEIDERS THOMAS JON112011–2014
WANG BOWEI112011–2015
Locations
LocationPatentsSpan
San Diego, California, US242006–2018
LaJolla, California, US32011–2013
La Jolla, California, US12011